ArticleCancers2025

Assessment of the PD-1/PD-L1/PD-L2 Immune Checkpoints Pathway in Endometrial Cancer and Its Clinical Significance.

Karolina Włodarczyk-Ciekańska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.